Sign in

CIK 0001785530

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823523180
Phone
+1 617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-01-06 Leonard Reid Chief Operating Officer Grant or award · Stock Option (Right to Buy) +70,967 70,967
2022-01-06 Trost Timothy W. Chief Financial Officer Grant or award · Stock Option (right to buy) +65,960 65,960
2022-01-06 HICKLIN DANIEL J Grant or award · Stock Option (right to buy) +215,888 215,888
2022-01-06 Lubman Ellen Chief Business Officer Grant or award · Stock Option (right to buy) +51,088 51,088
2022-01-06 Karunatilake Chulani Chief Technology Officer Grant or award · Stock Option (right to buy) +34,258 34,258
2022-01-06 Seidel-Dugan Cynthia Chief Scientific Officer Grant or award · Stock Option (right to buy) +79,516 79,516
2021-12-30 Leonard Reid Chief Operating Officer Exercise or conversion +14,102 $1.56 $22K 14,102
2021-12-30 Leonard Reid Chief Operating Officer Exercise or conversion · Stock Option (Right to Buy) −14,102 47,034
2021-12-15 Leonard Reid Chief Operating Officer Sale −2,865 $13.39 $38K 122,292
2021-12-15 Leonard Reid Chief Operating Officer Sale −135 $13.97 $2K 122,157
2021-10-28 Chatterjee Meeta Director Grant or award · Stock Option (right to buy) +23,200 23,200
2021-07-01 Karunatilake Chulani Chief Technology Officer Grant or award · Stock Option (right to buy) +272,000 272,000
2021-06-16 RA CAPITAL MANAGEMENT, L.P. Director Purchase +9,285 $13.37 $124K 4,291,881
2021-06-15 RA CAPITAL MANAGEMENT, L.P. Director Purchase +7,958 $12.95 $103K 4,282,596
2021-06-14 RA CAPITAL MANAGEMENT, L.P. Director Purchase +306,055 $12.75 $3.9M 4,274,638
2021-05-27 Sherman Michael A. Director Grant or award · Stock Option (right to buy) +23,200 23,200
2021-05-04 MPM BioVentures 2014, L.P. 10% owner Conversion +2,298,430 2,298,430
2021-05-04 MPM BioVentures 2014, L.P. 10% owner Conversion +763,809 3,062,239
2021-05-04 MPM BioVentures 2014, L.P. 10% owner Purchase +125,759 $16.00 $2.0M 3,187,998
2021-05-04 MPM BioVentures 2014, L.P. 10% owner Conversion · Series A Preferred Stock −19,925,321 0

Page 13 of 17 · 335 trades